Travere Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Travere Therapeutics, Inc. (NASDAQ: TVTX) announced its participation in two significant upcoming conferences. The SVB Securities Global Biopharma Conference is scheduled for February 15, 2023, at 3:00 p.m. ET, followed by the Barclays Global Healthcare Conference on March 15, 2023, at 11:15 a.m. ET. Live webcasts of each presentation will be available on Travere's Investor page, with replays accessible for up to 30 days post-event. Travere is dedicated to developing therapies for patients facing rare diseases, focusing on their urgent treatment needs and striving to offer hope through innovative solutions.

SAN DIEGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming conferences:

SVB Securities Global Biopharma Conference
Wednesday, February 15, 2023, at 3:00 p.m. ET

Barclays Global Healthcare Conference
Wednesday, March 15, 2023, at 11:15 a.m. ET

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations. Replays will be available for up to 30 days following each event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Naomi Eichenbaum
Vice President, Investor Relations
IR@travere.com
888-969-7879

FAQ

What conferences will Travere Therapeutics be participating in?

Travere Therapeutics will participate in the SVB Securities Global Biopharma Conference on February 15, 2023, and the Barclays Global Healthcare Conference on March 15, 2023.

When is the SVB Securities Global Biopharma Conference?

The SVB Securities Global Biopharma Conference is on February 15, 2023, at 3:00 p.m. ET.

When will the Barclays Global Healthcare Conference take place?

The Barclays Global Healthcare Conference will be held on March 15, 2023, at 11:15 a.m. ET.

Where can I watch live webcasts of Travere Therapeutics' presentations?

Live webcasts of Travere Therapeutics' presentations can be accessed on the Investor page of their website.

How long will the replays of the conference presentations be available?

Replays of the conference presentations will be available for up to 30 days following each event.

What is the focus of Travere Therapeutics?

Travere Therapeutics focuses on developing therapies for patients dealing with rare diseases, addressing urgent treatment needs.